We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
- Authors
Maggs, D G; Buchanan, T A; Burant, C F; Cline, G; Gumbiner, B; Hsueh, W A; Inzucchi, S; Kelley, D; Nolan, J; Olefsky, J M; Polonsky, K S; Silver, D; Valiquett, T R; Shulman, G I
- Abstract
Troglitazone is a new insulin-sensitizing agent used to treat type 2 diabetes mellitus. The mechanism by which troglitazone exerts its effect on systemic glucose metabolism is unknown.
- Publication
Annals of internal medicine, 1998, Vol 128, Issue 3, p176
- ISSN
0003-4819
- Publication type
Journal Article
- DOI
10.7326/0003-4819-128-3-199802010-00002